# Net Power Inc.: financial statements, quarterly NPWR · NYSE · CIK 1845437 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/npwr.md) · [Financials](/companies/npwr/financials.md) · [Filings](/companies/npwr/filings.md) · [Insiders](/companies/npwr/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/npwr/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-03-31) | Q2 FY2024 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.1](/filings/0001845437-24-000018.md) | [0.0](/filings/0001845437-24-000063.md) | [0.0](/filings/0001845437-25-000027.md) | [0.2](/filings/0001845437-25-000053.md) | [0.0](/filings/0001845437-25-000061.md) | [0.0 d](/filings/0001845437-26-000009.md) | [0.0](/filings/0001845437-25-000027.md) | [0.0](/filings/0001845437-25-000053.md) | [0.0](/filings/0001845437-25-000061.md) | [0.0 d](/filings/0001845437-26-000009.md) | not reported | not reported | | Cost of revenue | $m | not reported | [0.0](/filings/0001845437-24-000063.md) | [0.0](/filings/0001845437-25-000027.md) | [0.0](/filings/0001845437-25-000053.md) | [0.0](/filings/0001845437-25-000061.md) | [0.0 d](/filings/0001845437-26-000009.md) | [0.0](/filings/0001845437-25-000027.md) | [0.0](/filings/0001845437-25-000053.md) | [0.0](/filings/0001845437-25-000061.md) | [0.0 d](/filings/0001845437-26-000009.md) | not reported | not reported | | Gross profit | $m | [0.1](/filings/0001845437-24-000018.md) | [0.0](/filings/0001845437-24-000063.md) | [0.0](/filings/0001845437-25-000027.md) | [0.2](/filings/0001845437-25-000053.md) | [0.0](/filings/0001845437-25-000061.md) | [0.0 d](/filings/0001845437-26-000009.md) | [0.0](/filings/0001845437-25-000027.md) | [0.0](/filings/0001845437-25-000053.md) | [0.0](/filings/0001845437-25-000061.md) | [0.0 d](/filings/0001845437-26-000009.md) | not reported | not reported | | Research and development | $m | not reported | not reported | [11.2](/filings/0001845437-25-000027.md) | [15.5](/filings/0001845437-25-000053.md) | [17.3](/filings/0001845437-25-000061.md) | [19.8 d](/filings/0001845437-26-000009.md) | [22.6](/filings/0001845437-26-000019.md) | [26.6](/filings/0001845437-26-000033.md) | [24.5](/filings/0001845437-25-000061.md) | [25.7 d](/filings/0001845437-26-000009.md) | [19.7](/filings/0001845437-26-000019.md) | [4.2](/filings/0001845437-26-000033.md) | | Operating income | $m | [(17.0)](/filings/0001845437-24-000018.md) | [(38.7)](/filings/0001845437-24-000063.md) | [(38.8)](/filings/0001845437-25-000027.md) | [(44.9)](/filings/0001845437-25-000053.md) | [(47.2)](/filings/0001845437-25-000061.md) | [(50.4) d](/filings/0001845437-26-000009.md) | [(475)](/filings/0001845437-26-000019.md) | [(90.6)](/filings/0001845437-26-000033.md) | [(1,156)](/filings/0001845437-25-000061.md) | [(70.1) d](/filings/0001845437-26-000009.md) | [(34.2)](/filings/0001845437-26-000019.md) | [(210)](/filings/0001845437-26-000033.md) | | Income tax | $m | [0.0](/filings/0001845437-24-000018.md) | [(0.0)](/filings/0001845437-24-000063.md) | [(4.0)](/filings/0001845437-25-000027.md) | [(2.4)](/filings/0001845437-25-000053.md) | [(4.7)](/filings/0001845437-25-000061.md) | [0.6 d](/filings/0001845437-26-000009.md) | [0.4](/filings/0001845437-26-000019.md) | [(1.6)](/filings/0001845437-26-000033.md) | [(1.2)](/filings/0001845437-25-000061.md) | [(1.9) d](/filings/0001845437-26-000009.md) | [0.0](/filings/0001845437-26-000019.md) | [0.0](/filings/0001845437-26-000033.md) | | Net income | $m | [(17.1)](/filings/0001845437-24-000018.md) | [(30.6)](/filings/0001845437-24-000063.md) | [(11.4)](/filings/0001845437-25-000027.md) | [(4.3)](/filings/0001845437-25-000053.md) | [0.8](/filings/0001845437-25-000061.md) | [(34.3) d](/filings/0001845437-26-000009.md) | [(119)](/filings/0001845437-26-000019.md) | [(28.1)](/filings/0001845437-26-000033.md) | [(411)](/filings/0001845437-25-000061.md) | [(19.6) d](/filings/0001845437-26-000009.md) | [(9.9)](/filings/0001845437-26-000019.md) | [(80.3)](/filings/0001845437-26-000033.md) | | Diluted EPS | $ per share | [(4.55)](/filings/0001845437-24-000018.md) | [(0.44)](/filings/0001845437-24-000063.md) | [(0.16)](/filings/0001845437-25-000027.md) | [(0.06)](/filings/0001845437-25-000053.md) | [0.01](/filings/0001845437-25-000061.md) | not reported | [(1.55)](/filings/0001845437-26-000019.md) | [(0.36)](/filings/0001845437-26-000033.md) | [(5.28)](/filings/0001845437-25-000061.md) | not reported | [(0.12)](/filings/0001845437-26-000019.md) | [(0.91)](/filings/0001845437-26-000033.md) | | Basic EPS | $ per share | [(4.55)](/filings/0001845437-24-000018.md) | [(0.44)](/filings/0001845437-24-000063.md) | [(0.16)](/filings/0001845437-25-000027.md) | [(0.06)](/filings/0001845437-25-000053.md) | [0.01](/filings/0001845437-25-000061.md) | not reported | [(1.55)](/filings/0001845437-26-000019.md) | [(0.36)](/filings/0001845437-26-000033.md) | [(5.28)](/filings/0001845437-25-000061.md) | not reported | [(0.12)](/filings/0001845437-26-000019.md) | [(0.91)](/filings/0001845437-26-000033.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [545](/filings/0001845437-24-000063.md) | [537](/filings/0001845437-25-000008.md) | [429](/filings/0001845437-25-000027.md) | [405](/filings/0001845437-25-000053.md) | [386](/filings/0001845437-25-000061.md) | [329](/filings/0001845437-26-000009.md) | [300](/filings/0001845437-26-000019.md) | [284](/filings/0001845437-26-000033.md) | [229](/filings/0001845437-25-000061.md) | [199](/filings/0001845437-26-000033.md) | [133](/filings/0001845437-26-000019.md) | [118](/filings/0001845437-26-000033.md) | | Current assets | $m | [651](/filings/0001845437-23-000044.md) | [641](/filings/0001845437-25-000008.md) | [600](/filings/0001845437-24-000018.md) | [583](/filings/0001845437-24-000039.md) | [564](/filings/0001845437-24-000063.md) | [513](/filings/0001845437-26-000009.md) | [498](/filings/0001845437-25-000027.md) | [409](/filings/0001845437-25-000053.md) | [370](/filings/0001845437-25-000061.md) | [344](/filings/0001845437-26-000033.md) | [311](/filings/0001845437-26-000019.md) | [313](/filings/0001845437-26-000033.md) | | Total assets | $m | [2,491](/filings/0001845437-23-000044.md) | [2,471](/filings/0001845437-25-000008.md) | [2,445](/filings/0001845437-24-000018.md) | [2,357](/filings/0001845437-24-000039.md) | [2,337](/filings/0001845437-24-000063.md) | [2,294](/filings/0001845437-26-000009.md) | [1,839](/filings/0001845437-25-000027.md) | [1,789](/filings/0001845437-25-000053.md) | [630](/filings/0001845437-25-000061.md) | [600](/filings/0001845437-26-000033.md) | [543](/filings/0001845437-26-000019.md) | [338](/filings/0001845437-26-000033.md) | | Current liabilities | $m | [9.4](/filings/0001845437-23-000044.md) | [12.0](/filings/0001845437-25-000008.md) | [10.5](/filings/0001845437-24-000018.md) | [14.6](/filings/0001845437-24-000039.md) | [26.9](/filings/0001845437-24-000063.md) | [17.9](/filings/0001845437-26-000009.md) | [21.4](/filings/0001845437-25-000027.md) | [41.8](/filings/0001845437-25-000053.md) | [22.3](/filings/0001845437-25-000061.md) | [47.5](/filings/0001845437-26-000033.md) | [13.1](/filings/0001845437-26-000019.md) | [17.6](/filings/0001845437-26-000033.md) | | Total liabilities | $m | [229](/filings/0001845437-23-000044.md) | [140](/filings/0001845437-25-000008.md) | [150](/filings/0001845437-24-000018.md) | [116](/filings/0001845437-24-000039.md) | [90.8](/filings/0001845437-24-000063.md) | [132](/filings/0001845437-26-000009.md) | [40.4](/filings/0001845437-25-000027.md) | [59.0](/filings/0001845437-25-000053.md) | [47.4](/filings/0001845437-25-000061.md) | [64.5](/filings/0001845437-26-000033.md) | [24.9](/filings/0001845437-26-000019.md) | [25.5](/filings/0001845437-26-000033.md) | | Shareholders' equity | $m | [104](/filings/0001845437-23-000044.md) | [785](/filings/0001845437-25-000008.md) | [660](/filings/0001845437-24-000018.md) | [730](/filings/0001845437-24-000039.md) | [767](/filings/0001845437-24-000063.md) | [656](/filings/0001845437-26-000009.md) | [637](/filings/0001845437-25-000027.md) | [616](/filings/0001845437-25-000053.md) | [144](/filings/0001845437-25-000061.md) | [204](/filings/0001845437-26-000033.md) | [205](/filings/0001845437-26-000019.md) | [83.5](/filings/0001845437-26-000033.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2024 (2023-03-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(4.0) d](/filings/0001845437-24-000006.md) | [(5.1)](/filings/0001845437-24-000018.md) | [(2.7)](/filings/0001845437-25-000027.md) | [(8.2) d](/filings/0001845437-25-000053.md) | [(7.8) d](/filings/0001845437-25-000061.md) | [(13.0) d](/filings/0001845437-26-000009.md) | [(20.4)](/filings/0001845437-26-000019.md) | [(24.6) d](/filings/0001845437-26-000033.md) | [(48.0) d](/filings/0001845437-25-000061.md) | [(27.8) d](/filings/0001845437-26-000009.md) | [(51.1)](/filings/0001845437-26-000019.md) | [(9.6) d](/filings/0001845437-26-000033.md) | | Capital expenditure | $m | [0.1 d](/filings/0001845437-24-000006.md) | [0.6](/filings/0001845437-24-000018.md) | [9.5](/filings/0001845437-25-000027.md) | [7.8 d](/filings/0001845437-25-000053.md) | [22.3 d](/filings/0001845437-25-000061.md) | [29.1 d](/filings/0001845437-26-000009.md) | [8.9](/filings/0001845437-26-000019.md) | [3.1 d](/filings/0001845437-26-000033.md) | [3.1 d](/filings/0001845437-25-000061.md) | [18.1 d](/filings/0001845437-26-000009.md) | [8.2](/filings/0001845437-26-000019.md) | [0.8 d](/filings/0001845437-26-000033.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2024 (2023-03-31) | Q2 FY2024 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [3.7](/filings/0001845437-23-000010.md) | [1.1](/filings/0001845437-23-000044.md) | [3.7](/filings/0001845437-24-000018.md) | [69.0](/filings/0001845437-24-000063.md) | [71.9](/filings/0001845437-25-000027.md) | [72.2](/filings/0001845437-25-000053.md) | [73.5](/filings/0001845437-25-000061.md) | [77.0](/filings/0001845437-26-000019.md) | [77.7](/filings/0001845437-26-000033.md) | [77.9](/filings/0001845437-25-000061.md) | [85.4](/filings/0001845437-26-000019.md) | [88.4](/filings/0001845437-26-000033.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.